LianBio
LIANY- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831283
No open-market purchases or sales by LianBio insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $1.00K in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in LianBio as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- +1 vs. Q4 2021
- Shares held
- 85.9M
- −3.48M (−3.9%) vs. Q4 2021
- Total value
- $318.6M
- −$231.8M (−42.1%) vs. Q4 2021
- New holders
- 13
- 4 more added
- Sold out
- 12
- 5 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LIANY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $1.00K |
| Q1 2026 | 1 | $1.00K |
| Q4 2025 | 1 | $1.00K |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $5.00K |
| Q1 2025 | 1 | $2.00K |
| Q4 2024 | 2 | $42.1K |
| Q3 2024 | 2 | $47.3K |
| Q2 2024 | 2 | $50.5K |
| Q1 2024 | 3 | $49.2K |
| Q4 2023 | 29 | $377.3M |
| Q3 2023 | 38 | $117.7M |
| Q2 2023 | 39 | $182.9M |
| Q1 2023 | 36 | $157.1M |
| Q4 2022 | 40 | $133.3M |
| Q3 2022 | 44 | $168.0M |
| Q2 2022 | 44 | $187.1M |
| Q1 2022 | 37 | $318.6M |
| Q4 2021 | 36 | $550.5M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding LianBio; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 56,319,960 | $208.9M | 4.34% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 7,655,015 | $28.4M | 0.62% | 00.0% | Unchanged |
| VR Adviser, LLC | 5,378,341 | $20.0M | 3.23% | 00.0% | Unchanged |
| Tybourne Capital Management (HK) Ltd | 3,314,173 | $12.3M | 0.73% | 00.0% | Unchanged |
| Vida Ventures Advisors, LLC | 2,282,084 | $8.47M | 4.92% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 2,242,389 | $8.09M | 0.00% | 00.0% | Unchanged |
| Alliancebernstein L.P. | 1,518,969 | $5.63M | 0.00% | −1,685,761−52.6% | Reduced |
| Viking Global Investors LPSuperinvestorViking Global Investors | 1,500,000 | $5.57M | 0.02% | 00.0% | Unchanged |
| SCHF (Gpe), LLC | 937,500 | $3.48M | 1.08% | 00.0% | Unchanged |
| Hudson Bay Capital Management LP | 713,743 | $2.65M | 0.04% | 00.0% | Unchanged |
| Citadel Advisors LLC | 708,306 | $2.63M | 0.00% | +708,306 | New |
| Citigroup Inc | 533,795 | $1.98M | 0.00% | +533,795 | New |
| Logos Global Management LP | 412,837 | $1.53M | 0.20% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 339,242 | $1.26M | 0.01% | +54,392+19.1% | Added |
| Affinity Asset Advisors, LLC | 325,000 | $1.21M | 0.48% | +252,594+348.9% | Added |
| Sphera Funds Management Ltd. | 275,007 | $1.02M | 0.17% | 00.0% | Unchanged |
| Casdin Capital, LLC | 206,415 | $766.0K | 0.03% | 00.0% | Unchanged |
| Laurion Capital Management LP | 200,000 | $742.0K | 0.02% | 00.0% | Unchanged |
| Millennium Management LLC | 187,318 | $695.0K | 0.00% | −108,521−36.7% | Reduced |
| Victory Capital Management Inc | 173,460 | $664.0K | 0.00% | 00.0% | Unchanged |
| TD Asset Management Inc | 154,919 | $575.0K | 0.00% | 00.0% | Unchanged |
| Alps Advisors Inc | 110,219 | $409.0K | 0.00% | −11,597−9.5% | Reduced |
| MYDA Advisors LLC | 86,000 | $319.0K | 0.13% | +66,000+330.0% | Added |
| Manufacturers Life Insurance Company, The | 77,784 | $277.7K | 0.00% | +77,784 | New |
| Thrivent Financial for Lutherans | 49,505 | $184.0K | 0.00% | +49,505 | New |
| Goldman Sachs Group Inc | 43,185 | $160.0K | 0.00% | +43,185 | New |
| Bailard, Inc. | 36,900 | $137.0K | 0.00% | +36,900 | New |
| Renaissance Technologies LLC | 36,524 | $136.0K | 0.00% | +36,524 | New |
| UBS Group AG | 33,491 | $124.0K | 0.00% | +33,491 | New |
| Marshall Wace, LLP | 26,457 | $98.0K | 0.00% | −126,491−82.7% | Reduced |
| JPMorgan Chase & Co | 20,000 | $74.0K | 0.00% | +20,000 | New |
| Vident Investment Advisory, LLC | 19,913 | $74.0K | 0.00% | +19,913 | New |
| Old Well Partners, LLC | 19,200 | $71.0K | 0.05% | +7,500+64.1% | Added |
| Tower Research Capital LLC (TRC) | 5,903 | $22.0K | 0.00% | +5,903 | New |
| Morgan Stanley | 4,019 | $15.0K | 0.00% | +4,019 | New |
| FNY Investment Advisers, LLC | 800 | $2.00K | 0.00% | +800 | New |
| Bank of America Corp | 74 | $0 | 0.00% | −84,282−99.9% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −1,782,747−100.0% | Sold out |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −600,000−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −550,000−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −119,453−100.0% | Sold out |
| Pentwater Capital Management LP | 0 | $0 | 0.00% | −110,000−100.0% | Sold out |
| Ghisallo Capital Management LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −44,432−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −37,365−100.0% | Sold out |
| Element Capital Management LLC | 0 | $0 | 0.00% | −20,157−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −19,957−100.0% | Sold out |
| Cna Financial Corp | 0 | $0 | 0.00% | −15,993−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −11,095−100.0% | Sold out |